Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Prolonged Follow-up Confirmed a Role for Upfront Tandem Auto-Allo Transplant in Multiple Myeloma Also in the Era of New Drugs

Luisa Giaccone, Andrea Evangelista, Francesca Patriarca, Roberto Sorasio, MD, Massimo Pini, MD, Fabrizio Carnevale Schianca, MD, Moreno Festuccia, Lucia Brunello, Francesco Zallio, MD, Enrico Maffini, Paola Omedè, PhD, Sara Bringhen, MD, Nicola Mordini, MD, Renato Fanin, MD, Massimo Massaia, MD, Antonio Palumbo, MD, Giovannino Ciccone, MDPhD, Mario Boccadoro, MD, Benedetto Bruno, MD PhD

Blood (2016) 128 (22): 3469.

https://doi.org/10.1182/blood.V128.22.3469.3469

Published: 2016

Journal Articles

Allogeneic Stem Cell Transplantation Versus B-Cell-Receptor Inhibitors in 17p Deletion and/or Refractory Chronic Lymphocytic Leukemia: A Retrospective Comparative Analysis of 'Real Life' Approaches to High Risk Patients, on Behalf of Rete Ematologica Lombarda (REL) and Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Lucia Farina, MD PhD, Francesca Patriarca, Maddalena Mazzucchelli, Chiara Salvetti, MD, Giulia Quaresmini, Marta Medeot, MD, Daniele Vincenti, Gianluigi Reda, MD, Andrea Ferrario, MD, Francesco Zallio, MD, Anna Dodero, Benedetto Bruno, MD PhD, Paolo Corradini, Marco Montillo, MD

Blood (2016) 128 (22): 4695.

https://doi.org/10.1182/blood.V128.22.4695.4695

Published: 2016

Journal Articles

The Hypoxia-Inducible Factor-1alpha Is Constitutively Upregulated in TP53 Disrupted CLL Cells: A Potential Target to Overcome Fludarabine Resistance

Valentina Griggio, Ms, Candida Vitale, MD, Chiara Riganti, MD, Joanna Kopecka, PhD, Michele Dal Bo, Davide Rossi, MD PhD, Gabriele Pozzato, MD, Luca Laurenti, MD, Francesco Zallio, MD, Monia Marchetti, MD PhD, Marina Ruggeri, Paola Omedè, Giovanni Del Poeta, Pr, MD, Valter Gattei, MD, Gianluca Gaidano, MD PhD, Mario Boccadoro, MD, Massimo Massaia, MD, Marta Coscia, MD PhD

Blood (2015) 126 (23): 2925.

https://doi.org/10.1182/blood.V126.23.2925.2925

Published: 2015

Journal Articles

Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplant after Brentuximab Vedotin in Patients with Hodgkin Lymphoma Relapsed after Autologous Transplant

Francesco Zallio, MD, Alessandro Busca, MD, Nicola Mordini, Maria jose Fornaro, Benedetto Bruno, MD PhD, Gioacchino Catania, Flavia Salvi, MD, Guido Parvis, Marco Ladetto, Massimo Pini, MD

Blood (2014) 124 (21): 5943.

https://doi.org/10.1182/blood.V124.21.5943.5943

Published: 2014

Journal Articles

Monoclonal Gammopathy After Allogeneic Hematopoietic Stem Cell Transplant As a Marker For GvHD Onset

Federico Monaco, MD, Francesco Zallio, MD, Gioacchino Catania, MD, Maria Teresa Corsetti, MD, Lia Mele, Franco Dallavalle, MD, Anna Baraldi, MD, Flavia Salvi, MD, Massimo Pini, MD

Blood (2013) 122 (21): 5484.

https://doi.org/10.1182/blood.V122.21.5484.5484

Published: 2013

Journal Articles

Prolonged Survival Of Poor Risk Follicular Lymphoma Patients Following Primary Treatment With Rituximab-Supplemented CHOP Or HDS With Autograft: Long-Term Results Of The Multicenter Randomized GITMO/FIL Trial

Blood (2013) 122 (21): 551.

https://doi.org/10.1182/blood.V122.21.551.551

Published: 2013

Journal Articles

Hematological Improvement in AML/RAEB Elderly Patients Treated with Valproic Acid and Low-Dose ARA-C

Maria Teresa Corsetti, MD, Flavia Salvi, MD, Sonia Perticone, Bernardino Allione, MD, Anna Baraldi, MD, Alessandro Bellora, MD, Lorella De Paoli, MD, Simona Gatto, MD, Daniela Pietrasanta, MD, Valeria Primon, MD, Massimo Pini, MD, Anna Tonso, MD, Marco Musi, MD, Giorgio Ciravegna, MD, Francesco Zallio, MD, Alessandro Levis, MD

Blood (2008) 112 (11): 2971.

https://doi.org/10.1182/blood.V112.11.2971.2971

Published: 2008

Journal Articles

Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation (allo-SCT) Is an Effective Salvage Treatment for Peripheral T-Cell Non-Hodgkin’s Lymphoma (PTCL).

Paolo Corradini, MD, Anna Dodero, MD, Marco Bregni, MD, Francesco Zallio, MD, Lucia Farina, MD, Alessandro Rambaldi, MD, Francesca Patriarca, MD, Attilio Olivieri, MD, Francesca Bonifazi, MD, Alessandro Massimo Gianni, MD, Corrado Tarella, MD

Blood (2005) 106 (11): 1128.

https://doi.org/10.1182/blood.V106.11.1128.1128

Published: 2005

NARROW

Prolonged Follow-up Confirmed a Role for Upfront Tandem Auto-Allo Transplant in Multiple Myeloma Also in the Era of New Drugs

The Hypoxia-Inducible Factor-1alpha Is Constitutively Upregulated in TP53 Disrupted CLL Cells: A Potential Target to Overcome Fludarabine Resistance

Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplant after Brentuximab Vedotin in Patients with Hodgkin Lymphoma Relapsed after Autologous Transplant

Monoclonal Gammopathy After Allogeneic Hematopoietic Stem Cell Transplant As a Marker For GvHD Onset

Prolonged Survival Of Poor Risk Follicular Lymphoma Patients Following Primary Treatment With Rituximab-Supplemented CHOP Or HDS With Autograft: Long-Term Results Of The Multicenter Randomized GITMO/FIL Trial

Hematological Improvement in AML/RAEB Elderly Patients Treated with Valproic Acid and Low-Dose ARA-C

Reduced-Intensity Conditioning Followed by Allogeneic Stem Cell Transplantation (allo-SCT) Is an Effective Salvage Treatment for Peripheral T-Cell Non-Hodgkin’s Lymphoma (PTCL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only